Literature DB >> 15378058

Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.

Elmar Jaeckel1, Myra A Lipes, Harald von Boehmer.   

Abstract

Although autoimmune diseases can be initiated by immunization with a single antigen, it is not clear whether a single self antigen is essential for the initiation and, perhaps, the perpetuation of spontaneous autoimmunity. Some studies have suggested that insulin may represent an essential autoantigen in type 1 diabetes. Here we show that unlike tolerance to glutamic acid decarboxylase, tolerance to transgenically overexpressed preproinsulin 2 substantially reduced the onset and severity of type 1 diabetes in nonobese diabetic mice. However, some mice still developed type 1 diabetes, suggesting that insulin is a key, but not absolutely essential, autoantigen. The results are consistent with the idea that the human IDDM2 locus controls susceptibility to type 1 diabetes by regulating intrathymic preproinsulin expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378058     DOI: 10.1038/ni1120

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  57 in total

Review 1.  Treg vaccination with a strong-agonistic insulin mimetope.

Authors:  Benno Weigmann; Carolin Daniel
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

2.  Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells.

Authors:  Anthony N Vomund; Bernd H Zinselmeyer; Jing Hughes; Boris Calderon; Carolina Valderrama; Stephen T Ferris; Xiaoxiao Wan; Kohsuke Kanekura; Javier A Carrero; Fumihiko Urano; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 3.  Insulin as a key autoantigen in the development of type 1 diabetes.

Authors:  Maki Nakayama
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

4.  An immunologic homunculus for type 1 diabetes.

Authors:  Dirk Homann; George S Eisenbarth
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

5.  Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.

Authors:  Maki Nakayama; Joshua N Beilke; Jean M Jasinski; Masakazu Kobayashi; Dongmei Miao; Marcella Li; Marilyne G Coulombe; Edwin Liu; John F Elliott; Ronald G Gill; George S Eisenbarth
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

6.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

Review 7.  The central role of antigen presentation in islets of Langerhans in autoimmune diabetes.

Authors:  Boris Calderon; Javier A Carrero; Emil R Unanue
Journal:  Curr Opin Immunol       Date:  2013-11-16       Impact factor: 7.486

8.  Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.

Authors:  Gaurang Jhala; Jonathan Chee; Prerak M Trivedi; Claudia Selck; Esteban N Gurzov; Kate L Graham; Helen E Thomas; Thomas Wh Kay; Balasubramanian Krishnamurthy
Journal:  JCI Insight       Date:  2016-07-07

Review 9.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 10.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.